Metastatic Colorectal Cancers Active Not Recruiting Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03164655SULTAN (Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy Network)Treatment
NCT02292758Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryTreatment
NCT02743221A Study Evaluating S 95005 Plus Bevacizumab and Capecitabine Plus Bevacizumab in Patients With Previously Untreated Colorectal Cancer Who Are Non-eligible for Intensive TherapyTreatment
NCT02497157Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal CancerTreatment
NCT01516216Study of Vitamin D in Untreated Metastatic Colorectal CancerTreatment